Anti-PD-1 Immunotherapy Improves the Efficacy of Hepatic Artery Infusion Chemotherapy in Advanced Hepatocellular Carcinoma

Abstract

In comparison to HAIC, HAICAP was associated with a better treatment response and survival benefits for patients with advanced HCC.